1. Issue Highlights Clinical Gastroenterology and Hepatology
Stephen B. Hanauer 
Clinical Gastroenterology and Hepatology 
Volume 12, Issue 8, Pages (August 2014)
DOI: /j.cgh
Copyright © 2014 AGA Institute Terms and Conditions

2. Figure 1 FDA guidance for developing PROs.7
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions

3. Figure 2
PROs in FUSION: FACIT-F (A), CLDQ-HCV (B), and WPAI (C). FACIT-F scores are normalized to 0–1 range. Red circles and triangles represent the significance of the changes from the baseline for the respective scales.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions

4. Figure 3
PROs in NEUTRINO: FACIT-F (A), CLDQ-HCV (B), and WPAI (C). FACIT-F scores are normalized to 0–1 range. Red circles and triangles represent the significance of the changes from the baseline for the respective scales.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions